HEADER PLANT PROTEIN 06-SEP-04 1XDF TITLE CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR-10.2A FROM TITLE 2 YELLOW LUPINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PR10.2A; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: LLPR-10.2A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LUPINUS LUTEUS; SOURCE 3 ORGANISM_COMMON: YELLOW LUPINE; SOURCE 4 ORGANISM_TAXID: 3873; SOURCE 5 GENE: LLPR-10.2A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-3A KEYWDS 7-STRANDED ANTIPARALLEL BETA-SHEET, KINKED C-TERMINAL ALPHA-HELIX, KEYWDS 2 GLYCINE-RICH LOOP, PLANT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR O.PASTERNAK,J.BIESIADKA,R.DOLOT,L.HANDSCHUH,G.BUJACZ,M.M.SIKORSKI, AUTHOR 2 M.JASKOLSKI REVDAT 4 25-OCT-23 1XDF 1 REMARK LINK REVDAT 3 13-JUL-11 1XDF 1 VERSN REVDAT 2 24-FEB-09 1XDF 1 VERSN REVDAT 1 15-FEB-05 1XDF 0 JRNL AUTH O.PASTERNAK,J.BIESIADKA,R.DOLOT,L.HANDSCHUH,G.BUJACZ, JRNL AUTH 2 M.M.SIKORSKI,M.JASKOLSKI JRNL TITL STRUCTURE OF A YELLOW LUPIN PATHOGENESIS-RELATED PR-10 JRNL TITL 2 PROTEIN BELONGING TO A NOVEL SUBCLASS. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 61 99 2005 JRNL REFN ISSN 0907-4449 JRNL PMID 15608381 JRNL DOI 10.1107/S0907444904028173 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.BIESIADKA,G.BUJACZ,M.M.SIKORSKI,M.JASKOLSKI REMARK 1 TITL CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PATHOGENESIS-RELATED REMARK 1 TITL 2 PROTEINS FROM YELLOW LUPINE REMARK 1 REF J.MOL.BIOL. V. 319 1223 2002 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12079359 REMARK 1 DOI 10.1016/S0022-2836(02)00385-6 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.BIESIADKA,M.M.SIKORSKI,G.BUJACZ,M.JASKOLSKI REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY STRUCTURE REMARK 1 TITL 2 DETERMINATION OF LUPINUS LUTEUS PR10 PROTEIN REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 55 1925 1999 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 10531497 REMARK 1 DOI 10.1107/S0907444999011221 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.GAJHEDE,P.OSMARK,F.M.POULSEN,H.IPSEN,J.N.LARSEN, REMARK 1 AUTH 2 R.J.J.VAN NEERVEN,C.SCHOU,H.LOWENSTEIN,M.D.SPANGFORT REMARK 1 TITL X-RAY AND NMR STRUCTURE OF BET V 1, THE ORIGIN OF BIRCH REMARK 1 TITL 2 POLLEN ALLERGY REMARK 1 REF NAT.STRUCT.BIOL. V. 3 1040 1996 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 8946858 REMARK 1 DOI 10.1038/NSB1296-1040 REMARK 1 REFERENCE 4 REMARK 1 AUTH Z.MARKOVIC-HOUSLEY,M.DEGANO,D.LAMBA,E.VON ROEPENACK-LAHAYE, REMARK 1 AUTH 2 S.CLEMENS,M.SUSANI,F.FERREIRA,O.SCHEINER,H.BREITENEDER REMARK 1 TITL CRYSTAL STRUCTURE OF A HYPOALLERGENIC ISOFORM OF THE MAJOR REMARK 1 TITL 2 BIRCH POLLEN ALLERGEN BET V 1 AND ITS LIKELY BIOLOGICAL REMARK 1 TITL 3 FUNCTION AS A PLANT STEROID CARRIER REMARK 1 REF J.MOL.BIOL. V. 325 123 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12473456 REMARK 1 DOI 10.1016/S0022-2836(02)01197-X REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.19 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 28579 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1193 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1879 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2980 REMARK 3 BIN FREE R VALUE SET COUNT : 73 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2346 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 281 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 30.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.00000 REMARK 3 B22 (A**2) : 3.13000 REMARK 3 B33 (A**2) : -2.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.153 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.148 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.123 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.413 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2397 ; 0.019 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2195 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3239 ; 1.783 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5143 ; 0.926 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 312 ; 7.333 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 370 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2676 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 430 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 447 ; 0.222 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2484 ; 0.251 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1458 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 174 ; 0.171 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 3 ; 0.096 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 16 ; 0.226 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 46 ; 0.284 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.242 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1548 ; 1.779 ; 1.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2475 ; 3.013 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 849 ; 4.423 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 764 ; 6.230 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 157 REMARK 3 ORIGIN FOR THE GROUP (A): 14.5089 6.8831 13.2150 REMARK 3 T TENSOR REMARK 3 T11: 0.1161 T22: 0.0490 REMARK 3 T33: 0.0678 T12: 0.0127 REMARK 3 T13: 0.0185 T23: 0.0474 REMARK 3 L TENSOR REMARK 3 L11: 2.7777 L22: 2.2336 REMARK 3 L33: 2.4612 L12: 0.2806 REMARK 3 L13: -0.1057 L23: 0.7325 REMARK 3 S TENSOR REMARK 3 S11: 0.1609 S12: -0.1740 S13: -0.0604 REMARK 3 S21: -0.0968 S22: -0.0664 S23: -0.1641 REMARK 3 S31: -0.0070 S32: 0.1104 S33: -0.0945 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 157 REMARK 3 ORIGIN FOR THE GROUP (A): 14.5323 39.9558 18.2491 REMARK 3 T TENSOR REMARK 3 T11: 0.0735 T22: 0.0350 REMARK 3 T33: 0.1434 T12: 0.0276 REMARK 3 T13: 0.0357 T23: -0.0423 REMARK 3 L TENSOR REMARK 3 L11: 2.5619 L22: 2.8005 REMARK 3 L33: 3.3662 L12: -0.7007 REMARK 3 L13: 0.6043 L23: 0.5478 REMARK 3 S TENSOR REMARK 3 S11: 0.0011 S12: -0.0274 S13: 0.5174 REMARK 3 S21: -0.1269 S22: -0.0004 S23: -0.3532 REMARK 3 S31: -0.3342 S32: 0.0365 S33: -0.0008 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: H ATOMS AT RIDING POSITIONS WERE REMARK 3 INCLUDED IN FC CALCULATIONS; ONE OF THE TWO PROTEIN MOLECULES REMARK 3 COORDINATES A SODIUM CATION; THE REFINEMENT INCLUDED TLS REMARK 3 PARAMETERS; THE TIPS OF 6 SURFACE RESIDUES (1 IN MOL. A, 5 IN REMARK 3 MOL. B) HAVE NOT BEEN MEDELED BECAUSE OF MISSING ELECTRON REMARK 3 DENSITY, AND THE CORRESPONDING ATOMS ARE NOT INCLUDED IN THE REMARK 3 MODEL (SEE REMARK 470); REMARK 4 REMARK 4 1XDF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-SEP-04. REMARK 100 THE DEPOSITION ID IS D_1000030234. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9800 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30830 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.41200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1IFV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, HEPES, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.47800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.45900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.62150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.45900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.47800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.62150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAINS. THE PROTEIN IS MONOMERIC AND THE TWO REMARK 300 CHAINS, A AND B, ARE NOT INVOLVED IN QUATERNARY STRUCTURE FORMATION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 126 CG CD OE1 NE2 REMARK 470 GLU B 95 CG CD OE1 OE2 REMARK 470 ASP B 124 CG OD1 OD2 REMARK 470 GLN B 126 CG CD OE1 NE2 REMARK 470 GLU B 130 CG CD OE1 OE2 REMARK 470 LYS B 133 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 7 CB - CG - OD2 ANGL. DEV. = 6.9 DEGREES REMARK 500 ASP A 25 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 7 CB - CG - OD2 ANGL. DEV. = 7.9 DEGREES REMARK 500 ASP B 27 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 92 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 143 -86.71 -141.77 REMARK 500 GLU B 35 -66.84 -19.76 REMARK 500 GLU B 59 -72.51 -129.05 REMARK 500 ALA B 125 -147.20 70.51 REMARK 500 GLN B 126 51.29 -163.68 REMARK 500 ASN B 128 -88.06 -61.23 REMARK 500 GLU B 129 -43.13 -169.17 REMARK 500 PHE B 143 -80.46 -147.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 123 ASP B 124 147.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 PRO A 31 O REMARK 620 2 VAL A 34 O 93.3 REMARK 620 3 GLU A 35 O 163.1 76.4 REMARK 620 4 ILE A 37 O 99.7 86.9 93.1 REMARK 620 5 HOH A 473 O 78.2 94.7 89.3 177.4 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ICX RELATED DB: PDB REMARK 900 PATHOGENESIS-RELATED PROTEIN LLPR10.1A FROM YELLOW LUPINE. REMARK 900 RELATED ID: 1IFV RELATED DB: PDB REMARK 900 PATHOGENESIS-RELATED PROTEIN LLPR10.1B FROM YELLOW LUPINE. REMARK 900 RELATED ID: 1BV1 RELATED DB: PDB REMARK 900 MAJOR POLLEN ALLERGEN BETV 1, X-RAY STRUCTURE. REMARK 900 RELATED ID: 1FM4 RELATED DB: PDB REMARK 900 MAJOR POLLEN ALLERGEN BETV 1-L IN COMPLEX WITH DEOXYCHOLIC ACID. DBREF 1XDF A 1 157 UNP Q9LLQ3 Q9LLQ3_LUPLU 2 158 DBREF 1XDF B 1 157 UNP Q9LLQ3 Q9LLQ3_LUPLU 2 158 SEQRES 1 A 157 GLY VAL PHE THR PHE GLU ASP GLU SER THR SER THR ILE SEQRES 2 A 157 ALA PRO ALA ARG LEU TYR LYS ALA LEU VAL LYS ASP ALA SEQRES 3 A 157 ASP ALA ILE ILE PRO LYS ALA VAL GLU ALA ILE GLN SER SEQRES 4 A 157 ILE GLU THR VAL GLU GLY ASN GLY GLY PRO GLY THR ILE SEQRES 5 A 157 LYS LYS LEU THR LEU ILE GLU GLY GLY GLU THR LYS TYR SEQRES 6 A 157 VAL LEU HIS LYS ILE GLU ALA VAL ASP GLU ALA ASN LEU SEQRES 7 A 157 ARG TYR ASN TYR SER ILE VAL GLY GLY VAL GLY LEU PRO SEQRES 8 A 157 ASP THR ILE GLU LYS ILE SER PHE GLU THR LYS LEU VAL SEQRES 9 A 157 GLU GLY ALA ASN GLY GLY SER ILE GLY LYS VAL THR ILE SEQRES 10 A 157 LYS ILE GLU THR LYS GLY ASP ALA GLN PRO ASN GLU GLU SEQRES 11 A 157 GLU GLY LYS ALA ALA LYS ALA ARG GLY ASP ALA PHE PHE SEQRES 12 A 157 LYS ALA ILE GLU ASN TYR LEU SER ALA HIS PRO GLU TYR SEQRES 13 A 157 ASN SEQRES 1 B 157 GLY VAL PHE THR PHE GLU ASP GLU SER THR SER THR ILE SEQRES 2 B 157 ALA PRO ALA ARG LEU TYR LYS ALA LEU VAL LYS ASP ALA SEQRES 3 B 157 ASP ALA ILE ILE PRO LYS ALA VAL GLU ALA ILE GLN SER SEQRES 4 B 157 ILE GLU THR VAL GLU GLY ASN GLY GLY PRO GLY THR ILE SEQRES 5 B 157 LYS LYS LEU THR LEU ILE GLU GLY GLY GLU THR LYS TYR SEQRES 6 B 157 VAL LEU HIS LYS ILE GLU ALA VAL ASP GLU ALA ASN LEU SEQRES 7 B 157 ARG TYR ASN TYR SER ILE VAL GLY GLY VAL GLY LEU PRO SEQRES 8 B 157 ASP THR ILE GLU LYS ILE SER PHE GLU THR LYS LEU VAL SEQRES 9 B 157 GLU GLY ALA ASN GLY GLY SER ILE GLY LYS VAL THR ILE SEQRES 10 B 157 LYS ILE GLU THR LYS GLY ASP ALA GLN PRO ASN GLU GLU SEQRES 11 B 157 GLU GLY LYS ALA ALA LYS ALA ARG GLY ASP ALA PHE PHE SEQRES 12 B 157 LYS ALA ILE GLU ASN TYR LEU SER ALA HIS PRO GLU TYR SEQRES 13 B 157 ASN HET NA A 401 1 HET EPE A 301 15 HETNAM NA SODIUM ION HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN EPE HEPES FORMUL 3 NA NA 1+ FORMUL 4 EPE C8 H18 N2 O4 S FORMUL 5 HOH *281(H2 O) HELIX 1 1 ALA A 14 ASP A 25 1 12 HELIX 2 2 ASP A 25 VAL A 34 1 10 HELIX 3 3 GLU A 75 ASN A 77 5 3 HELIX 4 4 ASN A 128 ALA A 141 1 14 HELIX 5 5 PHE A 143 ALA A 152 1 10 HELIX 6 6 HIS A 153 ASN A 157 5 5 HELIX 7 7 ALA B 14 LYS B 24 1 11 HELIX 8 8 ASP B 25 VAL B 34 1 10 HELIX 9 9 GLU B 75 ASN B 77 5 3 HELIX 10 10 GLU B 129 ASP B 140 1 12 HELIX 11 11 PHE B 143 HIS B 153 1 11 HELIX 12 12 PRO B 154 ASN B 157 5 4 SHEET 1 A 7 VAL A 2 SER A 11 0 SHEET 2 A 7 SER A 111 THR A 121 -1 O SER A 111 N SER A 11 SHEET 3 A 7 ILE A 94 GLU A 105 -1 N LYS A 96 O GLU A 120 SHEET 4 A 7 ARG A 79 VAL A 85 -1 N TYR A 82 O PHE A 99 SHEET 5 A 7 GLU A 62 ASP A 74 -1 N ALA A 72 O ASN A 81 SHEET 6 A 7 ILE A 52 GLU A 59 -1 N LEU A 57 O LYS A 64 SHEET 7 A 7 ILE A 37 GLU A 44 -1 N GLU A 41 O LYS A 54 SHEET 1 B 7 VAL B 2 SER B 11 0 SHEET 2 B 7 SER B 111 THR B 121 -1 O VAL B 115 N ASP B 7 SHEET 3 B 7 ILE B 94 GLU B 105 -1 N GLU B 95 O GLU B 120 SHEET 4 B 7 ARG B 79 ILE B 84 -1 N TYR B 82 O PHE B 99 SHEET 5 B 7 THR B 63 ASP B 74 -1 N LYS B 69 O SER B 83 SHEET 6 B 7 ILE B 52 ILE B 58 -1 N LYS B 53 O HIS B 68 SHEET 7 B 7 ILE B 37 GLU B 44 -1 N SER B 39 O THR B 56 LINK O PRO A 31 NA NA A 401 1555 1555 2.31 LINK O VAL A 34 NA NA A 401 1555 1555 2.35 LINK O GLU A 35 NA NA A 401 1555 1555 2.92 LINK O ILE A 37 NA NA A 401 1555 1555 2.29 LINK NA NA A 401 O HOH A 473 1555 1555 2.79 SITE 1 AC1 5 PRO A 31 VAL A 34 GLU A 35 ILE A 37 SITE 2 AC1 5 HOH A 473 SITE 1 AC2 3 ASN A 77 ARG A 79 LYS A 102 CRYST1 48.956 69.243 112.918 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020427 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014442 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008856 0.00000